SG Americas Securities
ORGO icon

SG Americas Securities’s Organogenesis Holdings ORGO Stock Holding History

SG Americas Securities’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.88M Sell
772,737
-18,029
-2% -$44.1K ﹤0.01% 1542
2026
Q1 		$1.87M Buy
790,766
+225,265
+40% +$780K ﹤0.01% 1430
2025
Q4 		$2.93M Buy
565,501
+376,623
+199% +$1.82M ﹤0.01% 1336
2025
Q3 		$797K Sell
188,878
-175,969
-48% -$818K ﹤0.01% 1684
2025
Q2 		$1.33M Sell
364,847
-160,574
-31% -$599K 0.01% 979
2025
Q1 		$2.27M Buy
525,421
+483,675
+1,159% +$1.95M 0.01% 750
2024
Q4 		$134K Buy
41,746
+16,660
+66% +$55.9K ﹤0.01% 2506
2024
Q3 		$72K Buy
+25,086
New +$70.4K ﹤0.01% 3162
2024
Q2 		– Sell
-21,565
Closed -$61K – 3188
2024
Q1 		$61K Sell
21,565
-14,209
-40% -$48.3K ﹤0.01% 2704
2023
Q4 		$146K Buy
35,774
+6,727
+23% +$18.8K ﹤0.01% 2441
2023
Q3 		$92K Buy
+29,047
New +$92.3K ﹤0.01% 2816
2023
Q2 		– Sell
-29,786
Closed -$63K – 2935
2023
Q1 		$63K Buy
+29,786
New +$73.6K ﹤0.01% 3028
2022
Q4 		– Sell
-12,875
Closed -$42K – 3297
2022
Q3 		$42K Sell
12,875
-42,223
-77% -$191K ﹤0.01% 3020
2022
Q2 		$269K Buy
55,098
+26,568
+93% +$164K ﹤0.01% 2457
2022
Q1 		$217K Sell
28,530
-39,107
-58% -$303K ﹤0.01% 2384
2021
Q4 		$625K Buy
67,637
+20,107
+42% +$214K ﹤0.01% 1999
2021
Q3 		$677K Buy
+47,530
New +$738K ﹤0.01% 2250
2021
Q2 		– Sell
-126,435
Closed -$2.3M – 3129
2021
Q1 		$2.3M Buy
+126,435
New +$1.71M 0.01% 960
2020
Q3 		– Sell
-10,901
Closed -$42K – 3241
2020
Q2 		$42K Buy
+10,901
New +$39.3K ﹤0.01% 3557

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

SG Americas Securities's ORGO Position: Q2 2026 in Review

SG Americas Securities reduced its Organogenesis Holdings (ORGO) stake by 2.3% in Q2 2026, selling an estimated $44.1K and leaving 772,737 shares worth $1.88M. The position accounts for ﹤0.01% of the portfolio, ranked #1542.

SG Americas Securities first reported a position in ORGO in Q2 2020 and has held it in 19 quarters since. The position peaked at $2.93M in Q4 2025. 136 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • SG Americas Securities held 772,737 shares of Organogenesis Holdings worth $1.88M as of Q2 2026.
  • SG Americas Securities sold 18,029 Organogenesis Holdings shares in Q2 2026, an estimated $44.1K.
  • Organogenesis Holdings made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #1542 holding.
  • SG Americas Securities first reported a position in Organogenesis Holdings in Q2 2020 and has held it in 19 quarters since.
  • SG Americas Securities's Organogenesis Holdings position peaked at $2.93M in Q4 2025.
  • 136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.